|drug2477||Placebo Hydroxychloroquine Wiki||1.00|
|drug2478||Placebo Nitazoxanide Wiki||1.00|
|drug2481||Placebo Ribavirin Wiki||1.00|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
This study is a non-randomized, quasi-experimental, monocentric study comparing two prenatal monitoring modes in low-risk pregnancy: including at least one remote consultation (phone or teleconsultation) versus face-to-face adapted to confinement. The quality of care perceived by the pregnant women were evaluated according to monitoring modes set up during the COVID-19 pandemic confinement period. The women included planned to give birth at the regional academic Maternity of Nancy, France.
Description: score obtained with the Quality of prenatal care questionnaire (QPCQ) as close as possible after release from containmentMeasure: Score of perceived quality of prenatal care Time: Through study completion, an average of 3 months, ie either at the beginning of the second or the third trimester of pregnancy, or during immediate postpartum care
Description: Perceived stress measured with Perceived Stress Scale-10 (PSS-10) scaleMeasure: Level of stress during pregnancy Time: Through study completion, an average of 3 months, ie at the beginning of the second and the third trimester of pregnancy, and during immediate postpartum care
Description: level of health and digital literacy evaluated with Health Literacy Questionnaire (HLQ) and eHealth Literacy Questionnaire (eHLQ) questionnaireMeasure: level of health and digital literacy Time: Through study completion, an average of 3 months, ie at the beginning of the second and the third trimester of pregnancy, and during immediate postpartum care
Description: core set of outcomes for maternity careMeasure: Obstetrical outcomes Time: Through study completion, an average of 6 months, ie at the end of postpartum care hospitalization
Description: Number of remote, face-to-face or emergency consultations during pregnancy and requester of each consultation (patient or practitioner)Measure: Characteristics of medical supervision during pregnancy Time: Through study completion, an average of 6 months, ie throughout the period of pregnancy
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports